, Tracking Stock Market Picks
Enter Symbol:
Maxygen, Inc. (MAXY) [hlAlert]

down 30.11 %

Maxygen, Inc. (MAXY) rated Buy with price target $5 by Benchmark

Posted on: Tuesday,  Oct 14, 2008  9:25 AM ET by Benchmark

Benchmark rated Buy Maxygen, Inc. (NASDAQ: MAXY) on 10/14/2008, when the stock price was $3.62. Since
then, Maxygen, Inc. has lost 30.11% as of 08/29/2014's recent price of $2.53.
If you would have followed this Benchmark's recommendation on MAXY, you would have lost 30.11% of your investment in 2145 days.

Maxygen Inc. is a leader in the emerging field of directed molecular evolution, the process by which genes are modified for specificcommercial uses. The proprietary technologies, known as MolecularBreeding,mimic the natural process of evolution and bring together advances in molecular biology and classical breeding, while capitalizing on the large amount of genetic information generated by government, academic and commercial laboratories.

The Benchmark Company, LLC is a full-service Broker Dealer dedicated to meeting the needs of institutional and private clients. Operating from offices in New York, Boston, San Francisco, Philadelphia, Los Angeles and San Diego, Benchmark is committed to the highest standards of performance and service. This is a clear message to our clients that the company will continue to distinguish itself through outstanding service into the future.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/14/2008 9:25 AM Buy
3.62 5.00
as of 12/24/2008
1 Week up  0.32 %
1 Month down  -11.72 %
3 Months down  -31.61 %
1 YTD down  -31.61 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy